Study guide

Section 12.2: Sterile Compounding Regulations

Texas MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pharmacy Law Foundations & Regulators

Section 1.1: State and Federal Regulatory Bodies Section 1.2: Structure of Texas Pharmacy Law Section 1.3: TSBP Powers and Administrative Procedures Section 1.4: Inspections, Investigations, and Discipline

2 Chapter 2: Pharmacist Licensure & Continuing Education

Section 2.1: Initial Pharmacist Licensure & Reciprocity Section 2.2: License Renewal & Continuing Education Requirements Section 2.3: Inactive Status, Reinstatement, and Administrative Changes Section 2.4: Impaired Pharmacists & Peer Review Programs

3 Chapter 3: Pharmacy Personnel & Supervision Ratios

Section 3.1: Pharmacist-in-Charge (PIC) Responsibilities and Duties Section 3.2: Pharmacy Technicians and Technician Trainees Section 3.3: Pharmacist-to-Technician Supervision Ratios Section 3.4: Duties of Supportive Personnel

4 Chapter 4: Pharmacy Permits & Facility Classifications

Section 4.1: Texas Pharmacy Permit Classes Section 4.2: Class A (Community) Operations & Facilities Section 4.3: Class C (Institutional/Hospital) Operations & Facilities Section 4.4: Central Processing (Class G) and Non-Resident (Class E)

5 Chapter 5: Prescribers & Prescription Validity

Section 5.1: Texas Prescriptive Authority Section 5.2: General Prescription Requirements Section 5.3: Out-of-State and Canadian/Mexican Prescriptions Section 5.4: Self-Prescribing & Prescribing for Family Members

6 Chapter 6: Controlled Substances Schedules & Registration

Section 6.1: Federal vs. Texas Controlled Substances Schedules Section 6.2: DEA Registration & Texas Controlled Substances Act Section 6.3: Scheduled Listed Chemical Products Section 6.4: Controlled Substance Theft or Loss Reporting

7 Chapter 7: Controlled Substances Prescriptions & Dispensing

Section 7.1: CII Prescription Requirements and Validity Section 7.2: CII Refills, Partial Fills, and Emergency Oral Dispensing Section 7.3: CIII-CV Prescription Requirements, Validity, Refills, and Partial Fills Section 7.4: Opioid 10-day Initial Supply Limit & PMP Mandatory Queries

8 Chapter 8: Prescription Monitoring Program (PMP) & Drug Abuse

Section 8.1: Texas Prescription Monitoring Program Reporting & Database Section 8.2: Naloxone Access and Standing Orders in Texas Section 8.3: Corresponding Responsibility & Red Flags of Diversion Section 8.4: Treatment of Substance Use Disorders

9 Chapter 9: Dispensing Standards & Generic Substitution

Section 9.1: Texas Generic Substitution Law Section 9.2: Patient Counseling and Drug Utilization Review Requirements Section 9.3: Prescription Labeling Requirements in Texas Section 9.4: Poison Prevention Packaging Act & Child-Resistant Containers

10 Chapter 10: Prescription Refills, Transfers & Emergency Dispensing

Section 10.1: Prescription Refill Refusal & Professional Judgment Section 10.2: Prescription Transfer Rules Section 10.3: Emergency Refills (72-hour rule & 30-day natural disaster rule) Section 10.4: Return and Reuse of Prescription Medications

11 Chapter 11: Pharmacy Operations, Security & Recordkeeping

Section 11.1: Pharmacy Security, Alarms & Delivery of Drugs in Texas Section 11.2: General Recordkeeping & Document Retention Requirements Section 11.3: Controlled Substance Inventories Section 11.4: Disposal and Destruction of Controlled Substances

12 Chapter 12: Compounding Standards (Sterile & Non-Sterile)

Section 12.1: Non-Sterile Compounding Regulations Section 12.2: Sterile Compounding Regulations Section 12.3: Hazardous Drug Handling Section 12.4: Compounding Recordkeeping & Quality Control

13 Chapter 13: Specialized Pharmacy Practice & Public Safety

Section 13.1: Collaborative Practice Agreements & Drug Therapy Management Section 13.2: Pharmacist Immunization Authority & Protocol Requirements Section 13.3: Automated Dispensing Devices (Class A, C, and remote sites) Section 13.4: Public Health Laws (HIPAA, OBRA-90, DSCSA Drug Track and Trace)

Section 12.2: Sterile Compounding Regulations

Key Takeaways Explain This Topic AI

Pharmacies performing sterile compounding must hold a Class S permit modifier (e.g., Class A-S Community, Class C-S Institutional, Class E-S Non-Resident).

Pharmacists must complete at least 20 hours and pharmacy technicians at least 40 hours of initial ACPE-accredited sterile compounding training.

To renew a license or registration, sterile compounding personnel must complete 2 hours of ACPE-accredited CE for low/medium risk and 4 hours for high-risk (or Category 3) sterile compounding.

Environmental standards dictate an ISO Class 5 Primary Engineering Control (PEC), located within an ISO Class 7 buffer room, which opens into an ISO Class 8 anteroom.

Competency testing requires a gloved fingertip test (GFT) initially 3 times with 0 CFUs, and media-fill tests initially and then at least annually or semi-annually.

Last updated: July 2026

Section 12.2: Sterile Compounding Regulations

Sterile compounding involves preparing medications that must be free from viable microorganisms, pyrogens, and particulate matter. The Texas State Board of Pharmacy (TSBP) regulates these activities under 22 TAC §291.133 , which is designed to align with USP Chapter <797> standards.

Licensing and Class S Permits

In Texas, a pharmacy must obtain a special license modifier, known as a Class S permit, to engage in sterile compounding. This modifier is appended to the pharmacy's primary license class:

Class A-S: A community pharmacy that compounds sterile preparations.

Class C-S: An institutional (hospital) pharmacy that compounds sterile preparations.

Class E-S: A non-resident (out-of-state) pharmacy that compounds sterile preparations and ships them into Texas. Non-resident pharmacies must comply with TSBP sterile compounding rules and are subject to inspection by TSBP inspectors.

Personnel Training and Continuing Education (CE)

TSBP Rule §291.133 establishes non-negotiable minimum hours for sterile compounding training consisting of didactic instruction and practical experience:

Pharmacists: Must complete a minimum of 20 hours of instruction in sterile compounding through an accredited college of pharmacy or ACPE-accredited provider.

Pharmacy Technicians: Must complete a minimum of 40 hours of sterile compounding instruction through an ACPE-accredited provider or ASHP-accredited training program. A pharmacy technician trainee must complete this training before they are permitted to compound sterile preparations.

License Renewal CE: During each renewal cycle, personnel compounding Category 1 and 2 CSPs must complete at least 2 hours of ACPE-accredited CE related to sterile compounding. Those involved in high-risk sterile compounding (or Category 3 CSPs) must complete at least 4 hours of ACPE-accredited sterile compounding CE.

Cleanroom and Environmental standards

Sterile compounding must be performed in highly controlled environments divided into distinct zones, each subject to strict International Organization for Standardization (ISO) air quality classifications:

Primary Engineering Control (PEC): Provides an ISO Class 5 environment for exposure of critical sites during compounding. Common PECs include Laminar Airflow Workbenches (LAFW), Biological Safety Cabinets (BSC), and Compounding Aseptic Isolators (CAI).

Buffer Room (Cleanroom): The room where the PEC is located. It must maintain an ISO Class 7 air quality environment. For non-hazardous compounding, the buffer room must maintain positive pressure relative to the surrounding areas (at least 0.02 inches of water column) and have a minimum of 30 air changes per hour (ACPH).

Ante-room: The transition area where personnel perform hand hygiene and garbing. It must maintain an ISO Class 8 air quality environment. However, if the ante-room opens into a negative-pressure buffer room (used for hazardous compounding), it must maintain an ISO Class 7 air quality environment.

Segregated Compounding Area (SCA): A designated area containing an ISO Class 5 PEC, but the area itself is not ISO-classified. Compounding in an SCA is subject to severe beyond-use date restrictions.

  • Area ISO Air Quality Classification Pressure Requirement Air Changes Per Hour (ACPH)
  • PEC ISO Class 5 Positive (unless hazardous) Constant laminar flow
  • Buffer Room ISO Class 7 Positive (non-hazardous) / Negative (hazardous) Minimum 30 ACPH

Ante-room ISO Class 8 (positive buffer) / ISO Class 7 (negative buffer) Positive (relative to unclassified area) Minimum 20 ACPH

Competency Testing: Media-Fill and Gloved Fingertip Testing

Compounding personnel must demonstrate their aseptic technique through objective testing before they are allowed to prepare sterile medications for patient use:

Gloved Fingertip Testing (GFT): Evaluates a person's ability to garb and glove aseptically. Personnel must perform GFT by pressing their gloved fingertips onto agar plates.

Initial Competency: Personnel must pass GFT initially a minimum of three times (on separate garbing occasions) with zero colony-forming units (CFUs) on both hands.

Ongoing Competency: GFT must be repeated at least annually for Category 1 and 2 CSPs, and every three months for Category 3 CSPs. The passing threshold for ongoing GFT is 3 CFUs or fewer.

Media-Fill Testing: Evaluates aseptic technique by substituting growth-promoting media for the actual drug during a simulated compounding sequence.

Frequency: Must be passed initially, and then re-evaluated at least annually for Category 1 and 2 CSPs, and at least every six months for high-risk or Category 3 sterile compounding.

Outcome: The media-fill container must be incubated for 14 days and show zero evidence of microbial growth (turbidity) to pass.

Cleaning and Sanitization Frequencies

TSBP Rule §291.133 mandates minimal frequencies for cleaning and disinfecting sterile compounding areas. Cleaning must occur when no compounding is in progress:

PEC Work Surfaces: Cleaned and disinfected at the beginning of each shift, before each batch preparation, at least every 30 minutes during continuous compounding, after spills, and when contamination is suspected.

Counters, Work Surfaces, and Floors: Cleaned and disinfected at least daily .

Walls, Ceilings, and Shelving: Cleaned and disinfected at least monthly .

Beyond-Use Dates (2023 USP <797> Revisions)

Under the 2023 USP <797> revisions adopted by the TSBP, sterile compounded preparations are classified into three categories based on environmental controls and the complexity of the compounding process:

Category 1 CSPs: Compounded in a Segregated Compounding Area (SCA) with an ISO Class 5 PEC. The BUD is restricted to 12 hours or less at controlled room temperature or 24 hours or less if refrigerated .

Category 2 CSPs: Compounded in an ISO Class 7 buffer room with an ISO Class 5 PEC. The BUD depends on whether the compound is aseptically processed or terminally sterilized, whether a sterility test is performed, and the storage temperature. For an aseptically processed Category 2 CSP that does not undergo sterility testing, the maximum refrigerated BUD is 10 Days (refrigerated) or 4 Days (controlled room temperature).

Category 3 CSPs: Prepared under stricter environmental conditions than Category 2, including weekly cleaning, sterility testing, endotoxin testing, and stability-indicating assay data. The BUD can extend up to 180 days under refrigeration.